CUTX-101 of Fortress Biotech gets US FDA rare pediatric disease designation to treat Menkes disease
Fortress Biotech, an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and development-stage drugs and drug candidates, announced that... Read More